Kenneth Hoberman - Jun 16, 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Director
Signature
/s/ Kenneth Hoberman
Stock symbol
NVCT
Transactions as of
Jun 16, 2023
Transactions value $
$0
Form type
4
Date filed
6/20/2023, 08:15 AM
Previous filing
Jul 22, 2022
Next filing
Sep 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Award $0 +18K +32.64% $0.00 73.1K Jun 16, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The 18,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Hoberman's continued service on the board on such dates.